Cancer Institute A national cancer institute
designated cancer center

February 2012 Cancer Institute Bulletin


We are delighted to welcome Dr. Mark Pegram on his first day at Stanford!  Mark is head of the Breast Oncology Program and co-leader of the Molecular Therapeutics Program. He brings additional strong leadership in translational research to Stanford, as well as incredible energy and enthusiasm.

We are working hard to complete our strategic plan for cancer services and cancer research over the next five years. We appreciate all the effort that our membership has put into this process and look forward to rolling out the plan this spring. We look forward to working with the recently announced new Chairs of Medicine (Dr. Harrington) and Urology (Dr. Skinner), as well as the rest of our community to enhance cancer research and care.

We are also working to further develop our cancer genomics and broad scale sequencing capabilities as a basis for new targeted therapeutics. We plan to report more fully on this topic in coming months.


Tseng Memorial Lecture
  Wednesday, April 4th – 4:00 to 5:00 PM
Where:  LKSC, Berg Hall
Who:  Mary-Claire King, PhD
            Professor of Genome Sciences and of Medicine
            University of Washington School of Medicine

2012 SCI Member’s Retreat
  Monday, April 16th – 8:00 AM to 5:00 PM
Where:  Quadrus Conference Center, 2400 Sand Hill Road



The Samuel Waxman Cancer Research Foundation – Reprogramming the Cancer Cell Awards
Seeking projects related to differentiation therapy of cancer: the notion that the cancer cell can be re-programmed to re-acquire aspects of normal cell differentiation including terminal cell division and programmed cell death.
Funding: up to $100,000 per year for two years of direct costs
Internal DeadlineFebruary 15, 2012 by 4:00 p.m

Applicants must send one PDF file containing a two-page proposal and curriculum vitae to Denise Baughman, Project Manager at the Cancer Institute at:  

National Comprehensive Cancer Network - NCCN Foundation Young Investigator Awards
The NCCN Foundation invites proposals from young investigators (Instructors and Assistant Professors with PI eligibility) with interest in the development and application of the NCCN Clinical Practice Guidelines in Oncology. Projects may focus on guideline application in decision-making and formation of policies related to access to, availability and utilization of drugs, biologics, devices, procedures and techniques in cancer care.
Funding: $75,000 per year for two years
Internal DeadlineFebruary 20, 2012 by 4:00 p.m

Interested applicants can receive information on the Internal Submission Guidelines by contacting Denise Baughman, Project Manager at the Cancer Institute at:  


Biomedical Seminar - "Rethinking the replication/repair interface: A protection pathway connects Fanconi Anemia tumorsuppressors to RAD51 and BRCA1/2": Katharina Schlacher, PhD, Damon Runyon Fellow; Sloan-Kettering Institute
February 2, 2012 (Thurs.) | 11:00-12:00 pm |

 Regenerative Medicine Seminar Series (ReMS), "Modulators of Shh signaling: Novel Approaches”:  Roz Segal MD, PhD., Harvard, Dana Farber Cancer Institute
February 2, 2012 (Thurs.) | 12:00-1:00 pm |
Munzer Auditorium

Epidemiology Research Seminar – “The Epidemic of Melanoma in California: Recent Work Using California Cancer Registry Data”: Christina Clarke Dur, PhD, MPH, Research Scientist, Cancer Prevention Institute of California; Consulting Assistant Professor HRP (Epidemiology)
February 14, 2012 (Tues.) | 1:30-3:00 pm |
HRP Redwood Building, Room T138b

Epithelial Biology – “Oncogenic braf remodels the melanocyte transcriptome and induces the lncRNA BLNCR1 to regulate melanoma cell migration”, Ross Flockhart, Khavari Lab
February 17, 2012 (Fri.) | 9:00 – 10:00 am |
CCSR 4205

Epidemiology Research Seminar – “Predictors of Recurrence Among Women with Pre-Invasive Breast Cancer”:  Laurel Habel, PhD, Research Scientist III, Division of Research, Kaiser Permanente; Lecturer, HRP (Epidemiology)
February 21, 2012 (Tues.) | 1:30-3:00 pm |
HRP Redwood Building, Room T138b

Cancer Biology Seminar Series - “Oncogenic and Tumor Suppressor Function of Notch in Hematopoiesis and Leukemia”: Iannis Aifantis, PhD, Department of Pathology, NYU Howard Hughes Medical Institution
February 23, 2012 (Thurs.) | 12:00-1:30 pm |
Munzer Auditorium 

G-DOC®: A Systems Medicine Platform for Personalized Oncology, Subha Madhavan, Associate Professor, Georgetown University
February 23, 2012 (Tues.) | 5:30 – 6:30 pm |
LKSC 130

Epidemiology Research Seminar – “Roles of social networks in lay health worker interventions and colorectal cancer screening”
Bang Nguyen, DrPH Research Scientist, Cancer Prevention Institute of California; Consulting Assistant Professor HRP (Epidemiology) and Gem Le, PhD Research Scientist, Cancer Prevention Institute of California
February 28, 2012 (Tues.) | 1:30-3:00 pm |
HRP Redwood Building, Room T138b



You may suggest items for inclusion in the Bulletin at

Stanford Medicine Resources:

Footer Links: